View Clinical Trial (Medical Research Study)

Endoscopic Ultrasound (EUS) Guided Treatment With Humira for Crohn's Perianal Fistulas - NCT00517296-37232(Clinical Trial 180455)



ClinicalConnection.com has recently undergone an update and this page may no longer be up-to-date. Please Search For Clinical Trials to view the most current clinical trials listings.


Signup
City:  Nashville
State:  
TN
Zip Code: 37232
Conditions: Crohn Disease - Rectal Fistula
Purpose: This study is to assess whether utilizing endoscopic ultrasound(EUS) to guide treatment can improve durable fistula healing in patients with Crohn's perianal fistulas and to get preliminary information regarding the effectiveness of Adalimumab for Crohn's perianal fistulas.
Study summary:
Criteria: Inclusion Criteria: A patient may be considered for study participation if all of the following apply: - Male and Female aged 18 years or older; and - A confirmed diagnosis of Crohn's disease and one or more identifiable perianal fistulas. Exclusion Criteria: A patient will be excluded from the study if one or more of the following apply: - Females who are pregnant or breast feeding; - Infliximab received within 6 weeks prior to study entry; - Patients who cannot take, or refuse to take concomitant immunosuppressive therapy with either azathioprine, 6-mercaptopurine, or methotrexate; Unless patient has been intolerant of these therapies in the past or is contraindicated as determined by the investigator; - Patients who cannot take, or refuse to take concomitant antibiotic therapy; - Patients with severe anal stenosis or tenderness which would preclude colonoscopy and / or rectal EUS; - Patients who cannot take or refuse to take adalimumab; - Patients with active or latent tuberculosis; - Patients who have had systemic antibiotic, antiviral or antifungal treatment(s) within 3 weeks prior to Screening for all non-Crohn's related infections; - Patients concurrently taking anakinra (Kineret); - Patients with a history of cancer or lymphoproliferative disease other than a successfully and completely treated cutaneous squamous cell or basal cell carcinoma or carcinoma in-situ of the cervix; - Patients with chronic hematologic problems such as bleeding dyscrasias; - Patients with a history of demyelinating disease (i.e. multiple sclerosis); and - Patients with congestive heart failure.
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
Trials Alerts: If you would like to be notified of new clinical trials as they become available please register for a free account.
Data Source: ClinicalTrials.gov
Date Processed: June 11, 2010
Modifications to
this listing:		 Only selected fields are shown, please use the link above to view all information about this clinical trial.